ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,208Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 90

$937K Total Retail Price of All Prescriptions

Rank: 6 out of 90

782 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 782 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 782 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

4% of this provider’s 5,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $115 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 770 471 1 1
FUROSEMIDE 681 365 2 2
HYDROCODONE-ACETAMINOPHEN 643 140 S3 3 10
LISINOPRIL 578 254 4 3
ALLOPURINOL 392 246 5 13
LABETALOL HCL 367 164 6 39
SIMVASTATIN 316 103 7 12
CLONIDINE HCL 292 48 8 9
BENAZEPRIL HCL 279 155 9 25
CALCIUM ACETATE 253 39 10 8
METOPROLOL TARTRATE 224 98 11 7
ZOLPIDEM TARTRATE 195 48 12 30
NIFEDIPINE ER 193 49 13 19
GUANFACINE HCL 183 90 R 14 66
CARVEDILOL 172 99 15 6
OMEPRAZOLE 157 59 16 15
LOSARTAN POTASSIUM 153 70 17 17
SENSIPAR 143 0 18 5
NEXIUM 137 34 19 38
ATORVASTATIN CALCIUM 137 72 19 23
LEVOTHYROXINE SODIUM 137 97 19 21
DIOVAN 133 83 22 18
DOXAZOSIN MESYLATE 133 76 22 16
TRAMADOL HCL 132 63 24 26
RANITIDINE HCL 129 31 25 28
CALCITRIOL 128 92 26 14
HYDRALAZINE HCL 120 51 27 11
KLOR-CON M20 119 55 28 89
RENVELA 101 18 29 4
COLCRYS 92 51 30 46
AZITHROMYCIN 89 38 31 60
GABAPENTIN 87 32 32 22
ATENOLOL 85 42 33 37
CIPROFLOXACIN HCL 83 66 34 87
HYDROCHLOROTHIAZIDE 83 31 34 35
SPIRONOLACTONE 81 35 36 31
FLUOXETINE HCL 76 37 37 79
SPS 74 62 38 117
LIDOCAINE-PRILOCAINE 74 0 38 52
ALENDRONATE SODIUM 74 56 38 100
PREDNISONE 70 11 41 27
METOLAZONE 69 40 42 45
FAMOTIDINE 67 19 43 36
PANTOPRAZOLE SODIUM 65 28 44 48
CALCITONIN-SALMON 64 53 45 130
GLIPIZIDE 62 0 46 67
HECTOROL 60 40 47 86
PRAVASTATIN SODIUM 60 26 47 20
POTASSIUM CHLORIDE 59 42 49 54
DILTIAZEM ER 58 28 50 82
SERTRALINE HCL 58 0 50 75
AMITRIPTYLINE HCL 57 33 R 52 56
GLIPIZIDE ER 56 24 53 144
BYSTOLIC 54 22 54 41
TAMSULOSIN HCL 51 12 55 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.